Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Capital Expenditures (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Capital Expenditures for 4 consecutive years, with $38000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 74.5% to $38000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $827000.0 through Dec 2025, up 76.71% year-over-year, with the annual reading at $827000.0 for FY2025, 76.71% up from the prior year.
  • Capital Expenditures for Q4 2025 was $38000.0 at LENZ Therapeutics, down from $439000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $3.3 million in Q1 2022, with the low at $6000.0 in Q1 2023.
  • Average Capital Expenditures over 4 years is $657916.7, with a median of $213000.0 recorded in 2024.
  • The sharpest move saw Capital Expenditures tumbled 99.82% in 2023, then skyrocketed 136.02% in 2025.
  • Over 4 years, Capital Expenditures stood at $1.0 million in 2022, then plummeted by 99.41% to $6000.0 in 2023, then skyrocketed by 2383.33% to $149000.0 in 2024, then plummeted by 74.5% to $38000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $38000.0, $439000.0, and $240000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.